Mindbio Therapeutics Reports Secondary Data: Improvement of Psychological Outcomes & Safety Results in Depressed Patients from Phase 2A Depression Trial | Psychedelic Invest

TerXT is a combination of xanomeline and trospium prodrugs for the treatment of schizophrenia, and intends to pursue accelerated 505(b)(2) approval pathway Miami, FL – May 20, 2024 – Terran Biosciences Inc. (“Terran”), a biotech platform company developing therapeutics and technologies for patients with neuropsychiatric illnesses, has announced the development of TerXT, a combination of…

Talkspace, Bicycle Health Expands Access to Virtual Care for Patients with Opioid Use Disorder

What You Should Know: Today, Talkspace, the largest telemedicine-based therapy provider covered by insurance in the nation, and Bicycle Health, the leading telemedicine-based program for opioid use disorder

February 1, 2024

The ‘Holy Grail’ of Coding Automation: Why Inpatient AI is Around The Corner

Andrew Lockhart, CEO, Fathom Autonomous inpatient coding. This may sound like a pipe dream for revenue cycle leaders, whose hopes were likely raised and crushed

March 29, 2024

Carol Stonham MBE, RN, MSc, Queen’s Nurse, and Policy Lead PCRS joins the Bedfont® Medical Advisory Board

Bedfont® Scientific Ltd, a leading innovator in breath analysis medical device technology, is proud to announce the addition of Carol Stonham, a highly respected and

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.